[Omnic (tamsulosin) in the treatment of benign prostatic hyperplasia].
Lopatkin
N A
NA
Pytel'
Iu A
IuA
Trapeznikova
M F
MF
Loran
O B
OB
Mazo
E B
EB
Stepanov
V N
VN
Gres'
A A
AA
Savchenko
N E
NE
Vozianov
A F
AF
Babich
V M
VM
D000284:Administration, Oral; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D015415:Biomarkers / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000097:blood / Q000188:drug therapy*; D012449:Safety; D013449:Sulfonamides / Q000008:administration & dosage*; D000077409:Tamsulosin
D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D015415:Biomarkers; D013449:Sulfonamides; D017430:Prostate-Specific Antigen; D000077409:Tamsulosin